# Study to Evaluate the Adjunctive Effect of CreNeuroS™ CNS Fish Oil Plus Softgels in Patients With Major Depressive Disorder Receiving Escitalopram.

> **NCT07645807** · NA · NOT_YET_RECRUITING · sponsor: **Sichuan Credit Pharmaceutical Co., Ltd.** · enrollment: 80 (estimated)

## Conditions studied

- Adjunct in the Treatment of Depressive Disorder

## Interventions

- **COMBINATION_PRODUCT:** 1. Escitalopram (as escitalopram oxalate) tablet 2. CreNeuroSTM CNS Fish Oil Plus Softgels
- **COMBINATION_PRODUCT:** 1. Escitalopram (as escitalopram oxalate) tablet 2. Placebo softgels

## Key facts

- **NCT ID:** NCT07645807
- **Lead sponsor:** Sichuan Credit Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-06-11
- **Primary completion:** 2027-01
- **Final completion:** 2027-01
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2026-06-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07645807

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07645807, "Study to Evaluate the Adjunctive Effect of CreNeuroS™ CNS Fish Oil Plus Softgels in Patients With Major Depressive Disorder Receiving Escitalopram.". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07645807. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*